125 related articles for article (PubMed ID: 37490307)
1. Role of EGFL7 in human cancers: A review.
de Oliveira C; Gonçalves PG; Bidinotto LT
J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
[TBL] [Abstract][Full Text] [Related]
2. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
[TBL] [Abstract][Full Text] [Related]
3. Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer.
de Oliveira C; Martins SFF; Gonçalves PG; Limone GA; Longatto-Filho A; Reis RM; Bidinotto LT
Sci Rep; 2023 Nov; 13(1):19783. PubMed ID: 37957249
[TBL] [Abstract][Full Text] [Related]
4. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
Usuba R; Pauty J; Soncin F; Matsunaga YT
Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
[TBL] [Abstract][Full Text] [Related]
5. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
[TBL] [Abstract][Full Text] [Related]
6. EGFL7: a unique angiogenic signaling factor in vascular development and disease.
Nichol D; Stuhlmann H
Blood; 2012 Feb; 119(6):1345-52. PubMed ID: 22160377
[TBL] [Abstract][Full Text] [Related]
7. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia.
Bill M; Pathmanathan A; Karunasiri M; Shen C; Burke MH; Ranganathan P; Papaioannou D; Zitzer NC; Snyder K; LaRocco A; Walker AE; Brannan ZJ; Nalin AP; Freud AG; Dikov MM; Zhang X; Bloomfield CD; Garzon R; Dorrance AM
Clin Cancer Res; 2020 Feb; 26(3):669-678. PubMed ID: 31672772
[TBL] [Abstract][Full Text] [Related]
8. High
Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Qian T; Quan L; Cui W; Pan Y; Ye X; Shi J; Fu L
Cancer Biol Ther; 2019; 20(10):1314-1318. PubMed ID: 31306053
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.
Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R
Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612
[TBL] [Abstract][Full Text] [Related]
10. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
[TBL] [Abstract][Full Text] [Related]
11. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
[TBL] [Abstract][Full Text] [Related]
12. EGFL7 affects the migration of epidermal stem cells in refractory diabetic wounds by regulating Notch signaling pathway.
Chang J; Sun Y; Meng X; Zeng F; Wang X
Regen Med; 2023 Feb; 18(2):137-153. PubMed ID: 36530156
[TBL] [Abstract][Full Text] [Related]
13. EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling.
Wang Y; Chen P; Zhao M; Cao H; Zhao Y; Ji M; Hou P; Chen M
Cell Death Dis; 2022 Oct; 13(10):910. PubMed ID: 36309484
[TBL] [Abstract][Full Text] [Related]
14. LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus.
Zhou Q; Yu B; Anderson C; Huang ZP; Hanus J; Zhang W; Han Y; Bhattacharjee PS; Srinivasan S; Zhang K; Wang DZ; Wang S
Elife; 2019 Feb; 8():. PubMed ID: 30741632
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
16. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
[TBL] [Abstract][Full Text] [Related]
17. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7.
Nichol D; Shawber C; Fitch MJ; Bambino K; Sharma A; Kitajewski J; Stuhlmann H
Blood; 2010 Dec; 116(26):6133-43. PubMed ID: 20947685
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma.
Feleke M; Feng W; Song D; Li H; Rothzerg E; Wei Q; Kõks S; Wood D; Liu Y; Xu J
Exp Biol Med (Maywood); 2022 Jul; 247(14):1214-1227. PubMed ID: 35695550
[No Abstract] [Full Text] [Related]
19. EGFL7 ligates αvβ3 integrin to enhance vessel formation.
Nikolic I; Stankovic ND; Bicker F; Meister J; Braun H; Awwad K; Baumgart J; Simon K; Thal SC; Patra C; Harter PN; Plate KH; Engel FB; Dimmeler S; Eble JA; Mittelbronn M; Schäfer MK; Jungblut B; Chavakis E; Fleming I; Schmidt MHH
Blood; 2013 Apr; 121(15):3041-50. PubMed ID: 23386126
[TBL] [Abstract][Full Text] [Related]
20. Impact of Activation of
Sznurkowski JJ; Żawrocki A; Krawczyńska N; Bieńkowski M; Wasąg B; Biernat W
Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35630004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
